Science Explorer Interactive view Map
Company · Beijing · China

China National Pharmaceutical Group Corporation (China)

In research, China National Pharmaceutical Group Corporation (China) stands highest in Medicine (#3,321 of 10,443 worldwide), Health Sciences (#4,187 of 11,982 worldwide) and Life Sciences (#3,712 of 7,800 worldwide), 2022–2025.

sinopharm.com/1156.htmlROR OpenAlex
World rank, 2022–2025
#7,347
of 28,054 · #16,499 all time
Rank in China
#1,478
of 3,058
Research works
726
▼ 24% vs 2013–17
Citations
5.8k
7.9 per fractional work
Top-10% rate
21.1%
record average 16.5%
Open access
31%
world 28%

What is China National Pharmaceutical Group Corporation (China) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #3,321 of 10,443 22.4%84 #8752
Health SciencesDomain #4,187 of 11,982 22.6%90 #10446
Life SciencesDomain #3,712 of 7,800 20.3%74 #8230

Each strip is that field’s whole ranked pool, with the notch where China National Pharmaceutical Group Corporation (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#8,752 #3,321
  2. Health Sciences#10,446 #4,187
  3. Life Sciences#8,230 #3,712
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.32× its world share, 13 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.56× its world share, 39 worksBiochemistry, Geneti…Immunology and Microbiology: 4.77× its world share, 10 worksImmunology and Micro…Neuroscience: 1.77× its world share, 6 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.47× its world share, 6 worksPharmacology, Toxico…Chemical Engineering: 0.90× its world share, 1 worksChemical EngineeringChemistry: 2.09× its world share, 7 worksChemistryComputer Science: 0.27× its world share, 4 worksComputer ScienceEarth and Planetary Sciences: 0.17× its world share, 0 worksEarth and Planetary …Energy: 0.96× its world share, 2 worksEnergyEngineering: 0.43× its world share, 13 worksEngineeringEnvironmental Science: 0.48× its world share, 5 worksEnvironmental ScienceMaterials Science: 0.57× its world share, 4 worksMaterials ScienceMathematics: 0.05× its world share, 0 worksMathematicsPhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyDentistry: 0.68× its world share, 1 worksDentistryHealth Professions: 0.49× its world share, 3 worksHealth ProfessionsMedicine: 2.13× its world share, 84 worksMedicineNursing: 1.60× its world share, 2 worksNursingVeterinary: 1.19× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.17× its world share, 1 worksBusiness, Management…Decision Sciences: 0.17× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.18× its world share, 1 worksEconomics, Econometr…Psychology: 0.23× its world share, 2 worksPsychologySocial Sciences: 0.07× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.5×. Every wedge is a field page.

Which keywords describe research at China National Pharmaceutical Group Corporation (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Epidemiology, Inflammation, Pathogenesis, Vaccine, Immune Response, Oxidative Stress and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology20▲ 2.5×59 topics
  2. Cancer16▲ 5.9×38 topics
  3. Inflammation16▲ 3.7×63 topics
  4. Oxidative Stress10▲ 3.1×43 topics
  5. Pathogenesis8▲ 8.0×15 topics
  6. Vaccine8▲ 9.4×7 topics
  7. Immune Response8▲ 6.4×18 topics
  8. Cancer Therapy7▲ 6.0×13 topics
  9. Biomarkers7▲ 5.0×14 topics
  10. Cardiovascular Disease7▲ 3.0×27 topics
  11. Antioxidant7▲ 4.7×29 topics
  12. Biogenesis5▲ 14×3 topics
  13. Gene Expression5▲ 4.2×11 topics
  14. Tumor Microenvironment5▲ 5.4×8 topics
  15. Immunity5▲ 5.8×8 topics
  16. Regulation5▲ 4.4×8 topics
  17. Anti-inflammatory4▲ 7.9×19 topics
  18. Metastasis4▲ 6.3×9 topics
  19. Antioxidant Activity4▲ 3.3×18 topics
  20. Pharmacokinetics4▲ 7.9×9 topics
  21. Drug Delivery4▲ 3.8×8 topics
  22. Herbal Medicine4▲ 7.1×8 topics
  23. Neuroprotective Effects4▲ 12×7 topics
  24. Cell Death4▲ 8.2×4 topics
  25. Pharmacology4▲ 7.6×15 topics
  26. Coronavirus4▲ 8.7×2 topics
  27. Heart Failure4▲ 4.3×9 topics
  28. Innate Immunity4▲ 5.8×8 topics
  29. Pharmacological Effects4▲ 29×5 topics
  30. SARS-CoV-24▲ 5.5×5 topics
  31. Traditional Chinese Medicine4▲ 15×4 topics
  32. Phytochemistry4▲ 14×6 topics
  33. Flavonoids3▲ 6.3×10 topics
  34. Angiogenesis3▲ 4.9×11 topics
  35. Gene Therapy3▲ 8.4×5 topics
  36. ACE2 Receptor3▲ 6.3×3 topics
  37. Drug Discovery3▲ 6.5×8 topics
  38. Biological Activities3▲ 8.2×8 topics
  39. Therapeutics3▲ 12×2 topics
  40. Viral Transmission2▲ 8.2×2 topics

Which research topics does China National Pharmaceutical Group Corporation (China) publish most on?

By volume in 2022–2025: MicroRNA in disease regulation, Traditional Chinese Medicine Analysis, Viral gastroenteritis research and epidemiology and SARS-CoV-2 and COVID-19 Research.

MicroRNA in disease regu…2MicroRNA in disease regulation: 2 fractional worksTraditional Chinese Medi…2Traditional Chinese Medicine Analysis: 2 fractional worksViral gastroenteritis research and epidemiology: 2 fractional worksSARS-CoV-2 and COVID-19 …2SARS-CoV-2 and COVID-19 Research: 2 fractional worksVirus-based gene therapy…2Virus-based gene therapy research: 2 fractional worksPeptidase Inhibition and Analysis: 2 fractional worksAnimal Virus Infections Studies: 2 fractional worksHerpesvirus Infections a…2Herpesvirus Infections and Treatments: 2 fractional worksPARP inhibition in cancer therapy: 2 fractional worksExtracellular vesicles in disease: 2 fractional works
Cancer ResearchComplementary and alternative medicineInfectious DiseasesGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 MicroRNA in disease regulation Cancer Research 2 works
  2. 2 Traditional Chinese Medicine Analysis Complementary and alternative medicine 2 works
  3. 3 Viral gastroenteritis research and epidemiology Infectious Diseases 2 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  5. 5 Virus-based gene therapy research Genetics 2 works
  6. 6 Peptidase Inhibition and Analysis Oncology 2 works
  7. 7 Animal Virus Infections Studies Animal Science and Zoology 2 works
  8. 8 Herpesvirus Infections and Treatments Epidemiology 2 works
  9. 9 PARP inhibition in cancer therapy Oncology 2 works
  10. 10 Extracellular vesicles in disease Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.7%not open69.3%

World: 28% of research is openly available.

with international co-authors10.5%domestic only89.5%

World: 19% is written across borders.

How has China National Pharmaceutical Group Corporation (China)'s research output changed?

Output in 2018–2022 was 24% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.